Trial Outcomes & Findings for Achieving Nutritional Adequacy Of Vitamin E With An Egg/Plant-Based Food Pairing (NCT NCT04287816)

NCT ID: NCT04287816

Last Updated: 2025-12-02

Results Overview

Area under the concentration-time curve of plasma deuterium-labeled alpha-tocopherol over 72 hours post ingestion.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

8 participants

Primary outcome timeframe

0, 3, 4.5, 6, 7.5, 9, 12, 24, 36, 48, 72 hours post-ingestion of spinach

Results posted on

2025-12-02

Participant Flow

Participant milestones

Participant milestones
Measure
Sequence 1
Participants received the following interventions in order across 8 periods: Zero hard-boiled egg at 0 h One hard-boiled egg at 0 h Two hard-boiled eggs at 0 h Three hard-boiled eggs at 0 h Two egg whites at 0 h Vegetable oil at 0 h One hard-boiled egg at 3 h One hard-boiled egg at 0 h + One hard-boiled egg at 3 h
Sequence 2
Participants received one of the interventions listed in the periods. One hard-boiled egg at 0 h Two hard-boiled eggs at 0 h Three hard-boiled eggs at 0 h Two egg whites at 0 h Vegetable oil at 0 h One hard-boiled egg at 3 h One hard-boiled egg at 0 h + One hard-boiled egg at 3 h Zero hard-boiled egg at 0 h
Sequence 3
Participants received one of the interventions listed in the periods. Two hard-boiled eggs at 0 h Three hard-boiled eggs at 0 h Two egg whites at 0 h Vegetable oil at 0 h One hard-boiled egg at 3 h One hard-boiled egg at 0 h + One hard-boiled egg at 3 h Zero hard-boiled egg at 0 h One hard-boiled egg at 0 h
Sequence 4
Participants received one of the interventions listed in the periods. Three hard-boiled eggs at 0 h Two egg whites at 0 h Vegetable oil at 0 h One hard-boiled egg at 3 h One hard-boiled egg at 0 h + One hard-boiled egg at 3 h Zero hard-boiled egg at 0 h One hard-boiled egg at 0 h Two hard-boiled eggs at 0 h
Sequence 5
Participants received one of the interventions listed in the periods. Two egg whites at 0 h Vegetable oil at 0 h One hard-boiled egg at 3 h One hard-boiled egg at 0 h + One hard-boiled egg at 3 h Zero hard-boiled egg at 0 h One hard-boiled egg at 0 h Two hard-boiled eggs at 0 h Three hard-boiled eggs at 0 h
Sequence 6
Participants received one of the interventions listed in the periods. Vegetable oil at 0 h One hard-boiled egg at 3 h One hard-boiled egg at 0 h + One hard-boiled egg at 3 h Zero hard-boiled egg at 0 h One hard-boiled egg at 0 h Two hard-boiled eggs at 0 h Three hard-boiled eggs at 0 h Two egg whites at 0 h
Sequence 7
Participants received one of the interventions listed in the periods. One hard-boiled egg at 3 h One hard-boiled egg at 0 h + One hard-boiled egg at 3 h Zero hard-boiled egg at 0 h One hard-boiled egg at 0 h Two hard-boiled eggs at 0 h Three hard-boiled eggs at 0 h Two egg whites at 0 h Vegetable oil at 0 h
Sequence 8
Participants received one of the interventions listed in the periods. One hard-boiled egg at 0 h + One hard-boiled egg at 3 h Zero hard-boiled egg at 0 h One hard-boiled egg at 0 h Two hard-boiled eggs at 0 h Three hard-boiled eggs at 0 h Two egg whites at 0 h Vegetable oil at 0 h One hard-boiled egg at 3 h
SPINACH
STARTED
1
1
1
1
1
1
1
1
SPINACH
COMPLETED
1
1
1
1
1
1
1
1
SPINACH
NOT COMPLETED
0
0
0
0
0
0
0
0
Washout (1 Week)
STARTED
1
1
1
1
1
0
0
0
Washout (1 Week)
COMPLETED
1
1
1
1
1
0
0
0
Washout (1 Week)
NOT COMPLETED
0
0
0
0
0
0
0
0
SPINACH + 1 Egg (0 h)
STARTED
1
1
1
1
1
1
1
1
SPINACH + 1 Egg (0 h)
COMPLETED
1
1
1
1
1
1
1
1
SPINACH + 1 Egg (0 h)
NOT COMPLETED
0
0
0
0
0
0
0
0
SPINACH + 2 Eggs (0 h)
STARTED
1
1
1
1
1
1
1
1
SPINACH + 2 Eggs (0 h)
COMPLETED
1
1
1
1
1
1
1
1
SPINACH + 2 Eggs (0 h)
NOT COMPLETED
0
0
0
0
0
0
0
0
SPINACH + 3 Eggs (0 h)
STARTED
1
1
1
1
1
1
1
1
SPINACH + 3 Eggs (0 h)
COMPLETED
1
1
1
1
1
1
1
1
SPINACH + 3 Eggs (0 h)
NOT COMPLETED
0
0
0
0
0
0
0
0
SPINACH + WHITE
STARTED
1
1
1
1
1
1
1
1
SPINACH + WHITE
COMPLETED
1
1
1
1
1
1
1
1
SPINACH + WHITE
NOT COMPLETED
0
0
0
0
0
0
0
0
SPINACH + Oil
STARTED
1
1
1
1
1
1
1
1
SPINACH + Oil
COMPLETED
1
1
1
1
1
1
1
1
SPINACH + Oil
NOT COMPLETED
0
0
0
0
0
0
0
0
SPINACH + Egg (3 h)
STARTED
1
1
1
1
1
0
0
0
SPINACH + Egg (3 h)
COMPLETED
1
1
1
1
1
0
0
0
SPINACH + Egg (3 h)
NOT COMPLETED
0
0
0
0
0
0
0
0
SPINACH + Eggs (0 & 3 h)
STARTED
1
1
1
1
1
0
0
0
SPINACH + Eggs (0 & 3 h)
COMPLETED
1
1
1
1
1
0
0
0
SPINACH + Eggs (0 & 3 h)
NOT COMPLETED
0
0
0
0
0
0
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Baseline Characteristics
n=8 Participants
Characteristics of participants upon enrollment into the study
Age, Categorical
<=18 years
0 Participants
n=8 Participants
Age, Categorical
Between 18 and 65 years
8 Participants
n=8 Participants
Age, Categorical
>=65 years
0 Participants
n=8 Participants
Sex: Female, Male
Female
5 Participants
n=8 Participants
Sex: Female, Male
Male
3 Participants
n=8 Participants
Region of Enrollment
United States
8 participants
n=8 Participants
Body Mass Index
21.8 kg/m^2
STANDARD_DEVIATION 2.0 • n=8 Participants
Waist circumference Male
76.3 cm
STANDARD_DEVIATION 4.2 • n=8 Participants
Waist circumference Female
74.1 cm
STANDARD_DEVIATION 4.6 • n=8 Participants
Systolic blood pressure
109.6 mmHg
STANDARD_DEVIATION 8.3 • n=8 Participants
Diastolic blood pressure
70.8 mmHg
STANDARD_DEVIATION 5.4 • n=8 Participants
Total Cholesterol
4.19 mmol/L
STANDARD_DEVIATION 0.47 • n=8 Participants
Triglyceride
0.57 mmol/L
STANDARD_DEVIATION 0.15 • n=8 Participants
Total Lipid
4.75 mmol/L
STANDARD_DEVIATION 0.57 • n=8 Participants
Glucose
4.81 mmol/L
STANDARD_DEVIATION 0.39 • n=8 Participants

PRIMARY outcome

Timeframe: 0, 3, 4.5, 6, 7.5, 9, 12, 24, 36, 48, 72 hours post-ingestion of spinach

Area under the concentration-time curve of plasma deuterium-labeled alpha-tocopherol over 72 hours post ingestion.

Outcome measures

Outcome measures
Measure
SPINACH + 1 EGG0 h
n=8 Participants
Deuterium-labeled spinach containing 5 mg αT will be ingested along with 1 hard-boiled egg prior to the 72-h pharmacokinetics trial. One hard-boiled egg at 0 h: One egg will be consumed on test day along with spinach consumption
SPINACH + 2 EGGS0 h
n=8 Participants
Deuterium-labeled spinach containing 5mg αT will be ingested along with 2 hard-boiled eggs prior to the 72-h pharmacokinetics trial. Two hard-boiled eggs at 0 h: Two eggs will be consumed on test day along with spinach consumption
SPINACH + 3 EGGS0 h
n=8 Participants
Deuterium-labeled spinach containing 5 mg αT will be ingested along with 3 hard-boiled eggs prior to the 72-h pharmacokinetics trial. Three hard-boiled eggs at 0 h: Three eggs will be consumed on test day along with spinach consumption
SPINACH
n=8 Participants
No eggs will be consumed on the test day. Deuterium-labeled spinach containing 5 mg alpha-tocopherol (αT) will be ingested alone prior to the 72-h pharmacokinetics trial. Zero hard-boiled egg at 0 h: No eggs will be consumed on test day along with spinach consumption
SPINACH + WHITE
n=8 Participants
Deuterium-labeled spinach containing 5 mg αT will be ingested along with two egg whites prior to the 72-h pharmacokinetics trial. Two egg whites at 0 h: Two egg whites will be consumed on test day along with spinach consumption
SPINACH + OIL
n=8 Participants
Deuterium-labeled spinach containing 5 mg αT will be ingested along with 9.6 grams of vegetable oil prior to the 72-h pharmacokinetics trial. Vegetable oil at 0 h: 9.6 grams of Vegetable oil will be consumed on test day along with spinach consumption
SPINACH + EGG3 h
n=5 Participants
Deuterium-labeled spinach containing 5 mg αT will be ingested alone at 0 h prior to the 72-h pharmacokinetics trial followed by 1 hard-boiled egg 3 hours after spinach consumption. One hard-boiled egg at 3 h: One egg will be consumed on test day three hours after spinach consumption
SPINACH + EGGS0 & 3 h
n=5 Participants
Deuterium-labeled spinach containing 5 mg αT will be ingested along with 1 hard-boiled egg at 0 h prior to the 72-h pharmacokinetics trial followed by 1 egg 3 hours after spinach consumption. One hard-boiled egg at 0 h + One hard-boiled egg at 3 h: Two eggs will be consumed on test day: one along with spinach consumption and the other one three hours after spinach consumption
Vitamin E Area Under the Curve (0-72 h)
5.24 umol/L*h
Standard Error 1.00
5.18 umol/L*h
Standard Error 1.06
4.39 umol/L*h
Standard Error 0.69
2.90 umol/L*h
Standard Error 0.88
5.10 umol/L*h
Standard Error 0.65
6.88 umol/L*h
Standard Error 0.74
1.67 umol/L*h
Standard Error 0.45
4.88 umol/L*h
Standard Error 1.53

PRIMARY outcome

Timeframe: 0-72 hours post-ingestion of spinach

Maximum plasma concentration of deuterium-labeled alpha-tocopherol

Outcome measures

Outcome measures
Measure
SPINACH + 1 EGG0 h
n=8 Participants
Deuterium-labeled spinach containing 5 mg αT will be ingested along with 1 hard-boiled egg prior to the 72-h pharmacokinetics trial. One hard-boiled egg at 0 h: One egg will be consumed on test day along with spinach consumption
SPINACH + 2 EGGS0 h
n=8 Participants
Deuterium-labeled spinach containing 5mg αT will be ingested along with 2 hard-boiled eggs prior to the 72-h pharmacokinetics trial. Two hard-boiled eggs at 0 h: Two eggs will be consumed on test day along with spinach consumption
SPINACH + 3 EGGS0 h
n=8 Participants
Deuterium-labeled spinach containing 5 mg αT will be ingested along with 3 hard-boiled eggs prior to the 72-h pharmacokinetics trial. Three hard-boiled eggs at 0 h: Three eggs will be consumed on test day along with spinach consumption
SPINACH
n=8 Participants
No eggs will be consumed on the test day. Deuterium-labeled spinach containing 5 mg alpha-tocopherol (αT) will be ingested alone prior to the 72-h pharmacokinetics trial. Zero hard-boiled egg at 0 h: No eggs will be consumed on test day along with spinach consumption
SPINACH + WHITE
n=8 Participants
Deuterium-labeled spinach containing 5 mg αT will be ingested along with two egg whites prior to the 72-h pharmacokinetics trial. Two egg whites at 0 h: Two egg whites will be consumed on test day along with spinach consumption
SPINACH + OIL
n=8 Participants
Deuterium-labeled spinach containing 5 mg αT will be ingested along with 9.6 grams of vegetable oil prior to the 72-h pharmacokinetics trial. Vegetable oil at 0 h: 9.6 grams of Vegetable oil will be consumed on test day along with spinach consumption
SPINACH + EGG3 h
n=5 Participants
Deuterium-labeled spinach containing 5 mg αT will be ingested alone at 0 h prior to the 72-h pharmacokinetics trial followed by 1 hard-boiled egg 3 hours after spinach consumption. One hard-boiled egg at 3 h: One egg will be consumed on test day three hours after spinach consumption
SPINACH + EGGS0 & 3 h
n=5 Participants
Deuterium-labeled spinach containing 5 mg αT will be ingested along with 1 hard-boiled egg at 0 h prior to the 72-h pharmacokinetics trial followed by 1 egg 3 hours after spinach consumption. One hard-boiled egg at 0 h + One hard-boiled egg at 3 h: Two eggs will be consumed on test day: one along with spinach consumption and the other one three hours after spinach consumption
Vitamin E Cmax
0.18 umol/L
Standard Error 0.03
0.15 umol/L
Standard Error 0.03
0.14 umol/L
Standard Error 0.02
0.09 umol/L
Standard Error 0.02
0.15 umol/L
Standard Error 0.02
0.2 umol/L
Standard Error 0.02
0.06 umol/L
Standard Error 0.01
0.14 umol/L
Standard Error 0.04

SECONDARY outcome

Timeframe: 0-72 hours post-ingestion of spinach

Time to reach maximum plasma concentration of deuterium-labeled alpha-tocopherol

Outcome measures

Outcome measures
Measure
SPINACH + 1 EGG0 h
n=8 Participants
Deuterium-labeled spinach containing 5 mg αT will be ingested along with 1 hard-boiled egg prior to the 72-h pharmacokinetics trial. One hard-boiled egg at 0 h: One egg will be consumed on test day along with spinach consumption
SPINACH + 2 EGGS0 h
n=8 Participants
Deuterium-labeled spinach containing 5mg αT will be ingested along with 2 hard-boiled eggs prior to the 72-h pharmacokinetics trial. Two hard-boiled eggs at 0 h: Two eggs will be consumed on test day along with spinach consumption
SPINACH + 3 EGGS0 h
n=8 Participants
Deuterium-labeled spinach containing 5 mg αT will be ingested along with 3 hard-boiled eggs prior to the 72-h pharmacokinetics trial. Three hard-boiled eggs at 0 h: Three eggs will be consumed on test day along with spinach consumption
SPINACH
n=8 Participants
No eggs will be consumed on the test day. Deuterium-labeled spinach containing 5 mg alpha-tocopherol (αT) will be ingested alone prior to the 72-h pharmacokinetics trial. Zero hard-boiled egg at 0 h: No eggs will be consumed on test day along with spinach consumption
SPINACH + WHITE
n=8 Participants
Deuterium-labeled spinach containing 5 mg αT will be ingested along with two egg whites prior to the 72-h pharmacokinetics trial. Two egg whites at 0 h: Two egg whites will be consumed on test day along with spinach consumption
SPINACH + OIL
n=8 Participants
Deuterium-labeled spinach containing 5 mg αT will be ingested along with 9.6 grams of vegetable oil prior to the 72-h pharmacokinetics trial. Vegetable oil at 0 h: 9.6 grams of Vegetable oil will be consumed on test day along with spinach consumption
SPINACH + EGG3 h
n=5 Participants
Deuterium-labeled spinach containing 5 mg αT will be ingested alone at 0 h prior to the 72-h pharmacokinetics trial followed by 1 hard-boiled egg 3 hours after spinach consumption. One hard-boiled egg at 3 h: One egg will be consumed on test day three hours after spinach consumption
SPINACH + EGGS0 & 3 h
n=5 Participants
Deuterium-labeled spinach containing 5 mg αT will be ingested along with 1 hard-boiled egg at 0 h prior to the 72-h pharmacokinetics trial followed by 1 egg 3 hours after spinach consumption. One hard-boiled egg at 0 h + One hard-boiled egg at 3 h: Two eggs will be consumed on test day: one along with spinach consumption and the other one three hours after spinach consumption
Vitamin E Tmax (hr)
10.10 hr
Standard Error 0.55
10.90 hr
Standard Error 0.55
9.94 hr
Standard Error 0.63
9.64 hr
Standard Error 0.86
9.94 hr
Standard Error 0.63
9.38 hr
Standard Error 0.79
10.20 hr
Standard Error 0.74
9.90 hr
Standard Error 0.90

SECONDARY outcome

Timeframe: 0-72 hours post-ingestion of spinach

The time required for the plasma concentration of vitamin E to decrease by 50%.

Outcome measures

Outcome measures
Measure
SPINACH + 1 EGG0 h
n=8 Participants
Deuterium-labeled spinach containing 5 mg αT will be ingested along with 1 hard-boiled egg prior to the 72-h pharmacokinetics trial. One hard-boiled egg at 0 h: One egg will be consumed on test day along with spinach consumption
SPINACH + 2 EGGS0 h
n=8 Participants
Deuterium-labeled spinach containing 5mg αT will be ingested along with 2 hard-boiled eggs prior to the 72-h pharmacokinetics trial. Two hard-boiled eggs at 0 h: Two eggs will be consumed on test day along with spinach consumption
SPINACH + 3 EGGS0 h
n=8 Participants
Deuterium-labeled spinach containing 5 mg αT will be ingested along with 3 hard-boiled eggs prior to the 72-h pharmacokinetics trial. Three hard-boiled eggs at 0 h: Three eggs will be consumed on test day along with spinach consumption
SPINACH
n=8 Participants
No eggs will be consumed on the test day. Deuterium-labeled spinach containing 5 mg alpha-tocopherol (αT) will be ingested alone prior to the 72-h pharmacokinetics trial. Zero hard-boiled egg at 0 h: No eggs will be consumed on test day along with spinach consumption
SPINACH + WHITE
n=8 Participants
Deuterium-labeled spinach containing 5 mg αT will be ingested along with two egg whites prior to the 72-h pharmacokinetics trial. Two egg whites at 0 h: Two egg whites will be consumed on test day along with spinach consumption
SPINACH + OIL
n=8 Participants
Deuterium-labeled spinach containing 5 mg αT will be ingested along with 9.6 grams of vegetable oil prior to the 72-h pharmacokinetics trial. Vegetable oil at 0 h: 9.6 grams of Vegetable oil will be consumed on test day along with spinach consumption
SPINACH + EGG3 h
n=5 Participants
Deuterium-labeled spinach containing 5 mg αT will be ingested alone at 0 h prior to the 72-h pharmacokinetics trial followed by 1 hard-boiled egg 3 hours after spinach consumption. One hard-boiled egg at 3 h: One egg will be consumed on test day three hours after spinach consumption
SPINACH + EGGS0 & 3 h
n=5 Participants
Deuterium-labeled spinach containing 5 mg αT will be ingested along with 1 hard-boiled egg at 0 h prior to the 72-h pharmacokinetics trial followed by 1 egg 3 hours after spinach consumption. One hard-boiled egg at 0 h + One hard-boiled egg at 3 h: Two eggs will be consumed on test day: one along with spinach consumption and the other one three hours after spinach consumption
Half-Life (hr)
22.52 hr
Standard Error 3.26
26.92 hr
Standard Error 2.25
24.34 hr
Standard Error 3.65
25.36 hr
Standard Error 4.54
26.79 hr
Standard Error 1.57
30.45 hr
Standard Error 2.11
16.89 hr
Standard Error 2.53
21.24 hr
Standard Error 5.37

SECONDARY outcome

Timeframe: 0-72 hours post-ingestion of spinach

Absorption of deuterium-labeled alpha-tocopherol

Outcome measures

Outcome measures
Measure
SPINACH + 1 EGG0 h
n=8 Participants
Deuterium-labeled spinach containing 5 mg αT will be ingested along with 1 hard-boiled egg prior to the 72-h pharmacokinetics trial. One hard-boiled egg at 0 h: One egg will be consumed on test day along with spinach consumption
SPINACH + 2 EGGS0 h
n=8 Participants
Deuterium-labeled spinach containing 5mg αT will be ingested along with 2 hard-boiled eggs prior to the 72-h pharmacokinetics trial. Two hard-boiled eggs at 0 h: Two eggs will be consumed on test day along with spinach consumption
SPINACH + 3 EGGS0 h
n=8 Participants
Deuterium-labeled spinach containing 5 mg αT will be ingested along with 3 hard-boiled eggs prior to the 72-h pharmacokinetics trial. Three hard-boiled eggs at 0 h: Three eggs will be consumed on test day along with spinach consumption
SPINACH
n=8 Participants
No eggs will be consumed on the test day. Deuterium-labeled spinach containing 5 mg alpha-tocopherol (αT) will be ingested alone prior to the 72-h pharmacokinetics trial. Zero hard-boiled egg at 0 h: No eggs will be consumed on test day along with spinach consumption
SPINACH + WHITE
n=8 Participants
Deuterium-labeled spinach containing 5 mg αT will be ingested along with two egg whites prior to the 72-h pharmacokinetics trial. Two egg whites at 0 h: Two egg whites will be consumed on test day along with spinach consumption
SPINACH + OIL
n=8 Participants
Deuterium-labeled spinach containing 5 mg αT will be ingested along with 9.6 grams of vegetable oil prior to the 72-h pharmacokinetics trial. Vegetable oil at 0 h: 9.6 grams of Vegetable oil will be consumed on test day along with spinach consumption
SPINACH + EGG3 h
n=5 Participants
Deuterium-labeled spinach containing 5 mg αT will be ingested alone at 0 h prior to the 72-h pharmacokinetics trial followed by 1 hard-boiled egg 3 hours after spinach consumption. One hard-boiled egg at 3 h: One egg will be consumed on test day three hours after spinach consumption
SPINACH + EGGS0 & 3 h
n=5 Participants
Deuterium-labeled spinach containing 5 mg αT will be ingested along with 1 hard-boiled egg at 0 h prior to the 72-h pharmacokinetics trial followed by 1 egg 3 hours after spinach consumption. One hard-boiled egg at 0 h + One hard-boiled egg at 3 h: Two eggs will be consumed on test day: one along with spinach consumption and the other one three hours after spinach consumption
Estimated Absorption (%Dose) of Vitamin E
3.52 Percent
Standard Error 0.46
2.95 Percent
Standard Error 0.53
2.96 Percent
Standard Error 0.44
1.93 Percent
Standard Error 0.50
3.02 Percent
Standard Error 0.44
3.86 Percent
Standard Error 0.43
1.10 Percent
Standard Error 0.22
2.70 Percent
Standard Error 0.73

SECONDARY outcome

Timeframe: 0, 3, 4.5, 6, 7.5, 9, 12 hours post-ingestion of spinach

Population: Chylomicron measurements of vitamin E content were initially planned as part of the study protocol. While chylomicrons were isolated from blood samples and cryopreserved during the intervention, sample analysis was not performed because resources and personnel became unavailable. No data are available and these measures are not anticipated to be completed.

Deuterium-labeled alpha-tocopherol concentration in chylomicron

Outcome measures

Outcome data not reported

Adverse Events

Primary Study

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Exploratory Study

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Richard Bruno

Ohio State University

Phone: 6142925522

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place